A Single Dose Of HPV Vaccine May Provide Adequate Protection

NEW from the Frederick National Laboratory for Cancer Research, operated by Leidos Biomedical Research, Inc. for the National Cancer Institute.

Recent research adds to growing evidence that a single dose of human papillomavirus (HPV) vaccine is highly effective in protecting young women against cervical infection with cancer-causing HPV types. Read about the research, which involved Frederick National Laboratory.